NCT07636135 Timing of Rehabilitation Following Cervical Spinal Surgery in Degenerative Myelopathy
| NCT ID | NCT07636135 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alberta |
| Condition | Cervical Myelopathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-07-01 |
| Primary Completion | 2027-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-07-01 with a primary completion date of 2027-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn whether starting rehabilitation earlier after surgery can improve recovery and is feasible and acceptable for adults with degenerative cervical myelopathy (DCM) undergoing cervical spine surgery. The main question it aims to answer is: Does starting rehabilitation earlier improve walking, balance, physical activity, quality of life, and nervous system function after surgery? Researchers will compare participants who begin rehabilitation two weeks after surgery with participants who begin rehabilitation six weeks after surgery to see if earlier rehabilitation leads to better recovery outcomes and participation. Participants will: Be randomly assigned to begin rehabilitation either two weeks or six weeks after surgery. Attend physical therapy sessions twice per week for eight weeks focused on strength, balance, and walking. Complete assessments of walking ability, balance, physical activity, quality of life, and nervous system function over several months after surgery. Provide feedback about their experience with the rehabilitation program, including satisfaction and any side effects or challenges related to participation.
Eligibility Criteria
Inclusion Criteria: * adult (\>18 years of age) with diagnosis of degenerative cervical myelopathy, within 2 weeks of spinal decompression surgery * plan to be discharged home from acute care (i.e., not admitted to another facility for post-operative rehabilitation) * able to stand with a maximum of one-person assist (+/- use of gait aid) * persistent functional impairment in lower extremity strength, balance, coordination, and/or gait * ability to attend an 8-week in-person rehabilitation program in Edmonton, Alberta Exclusion Criteria: * discharge from acute care facility \> 2 weeks post-operative * intra-operative or early post-operative complication delaying discharge or precluding participation in early rehabilitation
Frequently Asked Questions
Who can join the NCT07636135 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cervical Myelopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07636135 currently recruiting?
Yes, NCT07636135 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Alberta to inquire about joining.
Where is the NCT07636135 trial being conducted?
This trial is being conducted at Edmonton, Canada.
Who is sponsoring the NCT07636135 clinical trial?
NCT07636135 is sponsored by University of Alberta. The trial plans to enroll 20 participants.